Last reviewed · How we verify
Clinical Efficacy and Mucosal/Systemic Antibody Response Changes After Sublingual Immunotherapy in Mite-allergic Children in a Randomized Double-blind, Placebo-controlled Study in Brazil (SLIT)
The purpose of this study is to evaluate the clinical efficacy and mucosal/systemic antibody response changes after SLIT using house dust mite allergen with or without bacterial extracts in mite-allergic children.
Details
| Lead sponsor | Federal University of Uberlandia |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 122 |
| Start date | 2008-10 |
| Completion | 2011-04 |
Conditions
- Allergic Rhinitis
Interventions
- Mite, Mite and Bacterial or Placebo
Primary outcomes
- Change from Baseline in Symptom and Medication Scores at 12 months — Baseline and 12 months
For clinical evaluation will be used a questionnaire determining the symptom and medication scores.
Countries
Brazil